Skip to main content

Market Overview

29 Healthcare Stocks Moving In Tuesday's After-Market Session

Share:

Gainers

Genprex, Inc. (NASDAQ:GNPX) stock surged 18.3% to $1.36 during Tuesday's after-market session.

Cutera, Inc. (NASDAQ:CUTR) stock increased by 8.9% to $33.80.

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) shares surged 7.8% to $3.16. According to the most recent rating by Bank of America, on November 15, the current rating is at Buy.

Menlo Therapeutics, Inc. (NASDAQ:MNLO) stock surged 7.4% to $6.93.

Sunesis Pharmaceuticals, Inc. (NASDAQ:SNSS) stock surged 7.4% to $0.58.

Anixa Biosciences, Inc. (NASDAQ:ANIX) stock increased by 7.2% to $4.00. The most recent rating by B. Riley, on December 30, is at Buy, with a price target of $8.00.

KemPharm, Inc. (NASDAQ:KMPH) shares surged 7.0% to $0.44. The most recent rating by H.C. Wainwright, on November 20, is at Buy, with a price target of $2.50.

Aethlon Medical, Inc. (NASDAQ:AEMD) shares rose 5.6% to $2.44.

Viking Therapeutics, Inc. (NASDAQ:VKTX) stock rose 5.5% to $7.48.

Athersys, Inc. (NASDAQ:ATHX) stock rose 4.7% to $1.34.

Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) shares rose 4.4% to $0.39.

Foamix Pharmaceuticals, Inc. (NASDAQ:FOMX) shares rose 4.3% to $4.82.

Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) stock increased by 3.7% to $2.23.

Oncolytics Biotech, Inc. (NASDAQ:ONCY) shares increased by 3.7% to $3.68.

Trillium Therapeutics, Inc. (NASDAQ:TRIL) stock surged 3.6% to $2.87.

Aduro Biotech, Inc. (NASDAQ:ADRO) shares moved upwards by 3.5% to $1.46. According to the most recent rating by Cowen & Co., on January 10, the current rating is at Market Perform.

Aevi Genomic Medicine, Inc. (NASDAQ:GNMX) stock moved upwards by 3.3% to $0.20.

Intrexon, Inc. (NASDAQ:XON) shares rose 3.1% to $5.80.

Assertio Therapeutics, Inc. (NASDAQ:ASRT) shares surged 3.1% to $1.34.

Intec Pharma, Inc. (NASDAQ:NTEC) stock rose 3.0% to $0.58.

 

Losers

Novavax, Inc. (NASDAQ:NVAX) stock decreased by 10.7% to $8.77 during Tuesday's after-market session.

Sophiris Bio, Inc. (NASDAQ:SPHS) stock fell 8.3% to $0.80.

Adaptimmune Therapeutics, Inc. (NASDAQ:ADAP) shares fell 5.3% to $3.92.

Durect, Inc. (NASDAQ:DRRX) shares decreased by 4.7% to $2.01. The most recent rating by Cantor Fitzgerald, on November 18, is at Overweight, with a price target of $5.00.

Lannett, Inc. (NYSE:LCI) stock fell 4.4% to $9.07.

Amneal Pharmaceuticals, Inc. (NYSE:AMRX) stock decreased by 4.1% to $5.11. The most recent rating by RBC Capital, on January 02, is at Sector Perform, with a price target of $4.00.

Solid Biosciences, Inc. (NASDAQ:SLDB) stock declined 3.7% to $3.61. The most recent rating by Nomura, on December 19, is at Buy, with a price target of $10.00.

DBV Technologies, Inc. (NASDAQ:DBVT) shares fell 3.6% to $12.00. The most recent rating by Stifel, on January 09, is at Buy, with a price target of $18.00.

IMAC Holdings, Inc. (NASDAQ:IMAC) stock fell 3.1% to $1.26. According to the most recent rating by Dawson James, on January 14, the current rating is at Neutral.

 

Related Articles (CUTR + GNPX)

View Comments and Join the Discussion!

Posted-In: healthcare stocksAfter-Hours Center Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com